Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform
Provided By GlobeNewswire
Last update: May 21, 2025
The Company demonstrated strong mucoadhesion and broad surface coverage in ex vivo nasal tissue models
Raanana, Israel, May 21, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced compelling results from recent ex vivo studies demonstrating the mucoadhesive strength and extensive nasal surface coverage of its proprietary formulation platform.
Read more at globenewswire.com1.04
+0.36 (+52.47%)
Find more stocks in the Stock Screener
PLRZ Latest News and Analysis
11 hours ago - ChartmillWhich stocks are moving on Tuesday?Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
12 hours ago - ChartmillDiscover the most active stocks in Tuesday's session.Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume!
14 hours ago - ChartmillWhich stocks are moving on Tuesday?Curious about what's happening in today's session? Check out the latest stock movements and price changes.
16 hours ago - ChartmillThere are notable gap-ups and gap-downs in today's session.Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
